Larimar Therapeutics
investment highlights | Larimar Therapeutics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
3 of 44
Similar slides by Larimar Therapeutics
See diffirences between slides (animation)
Investor Presentation
November 2023
investment highlights | Larimar Therapeutics
Related slides by other companies
NeuroSense Therapeutics
Investor Presentation
October 2024
paradigm phase trial design | NeuroSense Therapeutics
ATAI
Investor Presentation
April 2023
summary has previously shown pro cognitive effects in | ATAI
ATAI
Investor Presentation
March 2023
phase proof of concept trial design all subjects tid tid placebo trial status in data anticipated randomized week study of and patients with | ATAI
ATAI
Investor Presentation
March 2023
changes in beta power from dose to hour post dose placebo low doses high doses no significant change significant increase preliminary data subject to change phase dose dependent frontal was demonstrated providing evidence of target engagement and mechanism of action a a | ATAI
Other recent decks by Larimar Therapeutics
See all presentations (3 decks)
Results
November 2022
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights